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Abstract
Background: Gout is a prevalent inflammatory arthritis affecting 1–2% of adults characterized by activation of innate
immune cells by monosodium urate (MSU) crystals resulting in the secretion of interleukin-1b (IL-1b). Since neutrophils play
a major role in gout we sought to determine whether their activation may involve the formation of proinflammatory
neutrophil extracellular traps (NETs) in relation to autophagy and IL-1b.
Methodology/Principal Findings: Synovial fluid neutrophils from six patients with gout crisis and peripheral blood
neutrophils from six patients with acute gout and six control subjects were isolated. MSU crystals, as well as synovial fluid or
serum obtained from patients with acute gout, were used for the treatment of control neutrophils. NET formation was
assessed using immunofluorescence microscopy. MSU crystals or synovial fluid or serum from patients induced NET
formation in control neutrophils. Importantly, NET production was observed in neutrophils isolated from synovial fluid or
peripheral blood from patients with acute gout. NETs contained the alarmin high mobility group box 1 (HMGB1) supporting
their pro-inflammatory potential. Inhibition of phosphatidylinositol 3-kinase signaling or phagolysosomal fusion prevented
NET formation, implicating autophagy in this process. NET formation was driven at least in part by IL-1b as demonstrated by
experiments involving IL-1b and its inhibitor anakinra.
Conclusions/Significance: These findings document for the first time that activation of neutrophils in gout is associated
with the formation of proinflammatory NETs and links this process to both autophagy and IL-1b. Modulation of the
autophagic machinery may represent an additional therapeutic study in crystalline arthritides.
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Introduction
Acute gout is a prevalent inflammatory arthritis that results
from monosodium urate (MSU) crystal deposition. It affects up to
1–2% of adults and is the most common inflammatory arthritis in
men [1]. MSU crystals are endogenous danger signals, which
activate articular resident cells of the monocyte/macrophage
lineage, resulting in the triggering of inflammatory attacks [2,3,4].
Even though several proinflammatory cytokines and chemokines
have been associated with the early phase of acute gouty arthritis,
growing evidence derived from experimental and clinical studies
indicates a pivotal role for interleukin-1b (IL-1b) in the initiation of
inflammation. Activation of NLRP3 inflammasome by MSU
crystals is thought to regulate pro-IL-1b processing during gout
[5,6]. Moreover, neutrophil-derived proteases have been reported
to contribute to IL-1b production [7]. Inhibition of IL-1b signaling
is effective in the resolution of gouty inflammation in both animal
models [8,9] and in humans [10–13].
In gout, initial activation of articular cells by MSU crystals is
followed by the recruitment and ingress of large numbers of
neutrophils into the inflamed joints [14]. In vitro studies have
previously attempted to elucidate the mechanism that drives
neutrophil activation by MSU-crystals and proposed the stimula-
tion of several kinases including Src-family tyrosine kinase [15],
protein kinase C [16] and phosphatidylinositol 3-kinases (PI3Ks)
[17,18] as key signaling events in this process.
PI3K signaling has been previously implicated in the initiation
of autophagy in human neutrophils in response to several
inflammatory stimuli [19]. Autophagy constitutes a critical cellular
mechanism for the preservation of cell integrity, while it is
implicated in the regulation of innate immune functions [20].
Recent data suggest that autophagy is required for NETosis, a
distinct form of neutrophil cell death, characterized by the release
of neutrophil extracellular traps (NETs) [21].
NETs are extracellular fibrous structures composed of chroma-
tin and granule constituents of neutrophils [22]. NET formation
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stimuli has been recently described as an extracellular antimicro-
bial process, critical for neutrophil physiology [22]. It is suggested
that capture and killing of microbes by the formation of NETs
constitutes an additional mechanism for pathogen elimination
which expands neutrophil microbicidal activity after cell death
[22,23]. However, NET release from cells not undergoing
NETosis has also been reported [24]. The localization of several
neutrophil enzymes with proinflammatory function, like elastase,
myeloperoxidase (MPO) or proteinase 3, to NETs and the
increasing evidence for the implication of NETs in non-infectious
diseases, including asthma [25], ulcerative colitis [26] and systemic
lupus erythematosus (SLE) [27–29], suggest a role for the
formation of these structures in the amplification of the
inflammatory responses that characterize these disorders.
Since both neutrophils and IL1b play a major role in the
pathogenesis of acute gout, we studied the generation of NETs
during acute gout and its relation to autophagy and IL-1b. Herein,
we report for the first time proinflammatory NET formation from
neutrophils derived from synovial fluid and peripheral neutrophils
from patients with acute gout and control neutrophils stimulated
with MSU crystals. We also present data linking this to autophagy
and IL-1b.
Results
MSU crystals induce the formation of NETs
The ability of MSU crystals to induce neutrophil activation and
NET release was initially studied by treating peripheral polymor-
phonuclear cells (PMNs) with MSU crystals for 5 min, 30 min,
90 min and 3 h. The presence of web-like structures, visualized by
co-staining with diamidino-2-phenylindole (DAPI) and MPO, was
observed after 90 min of treatment and was prominent at 3 h
(Fig. 1), indicating the formation of NETs [23]. To examine the
possible implication of the autophagic machinery in the release of
these structures, 3-methyladenine (3-MA), an inhibitor of class III
phosphatidylinositol 3-kinase (PI3K) signaling [19], LY294002
(Fig. S1), a pan-PI3K inhibitor, or bafilomycin A, which prevents
autophagosome maturation by inhibiting their fusion with
lysosomes [30], were used. Treatment of PMNs with these agents
30 min after the addition of MSU crystals significantly diminished
the percentage of cells releasing the aforementioned structures
(Fig. 2). On the other hand, Src kinase inhibition had no effect on
NET formation (Fig 2B, Fig. S1).
Moreover, the activation of autophagy in PMNs treated with
MSU crystals was assessed by endogenous LC3B immunofluores-
cence. LC3B punctuated structures, associated with autophagy
induction, were observed in cells treated for both selected time
points, 20 min and 60 min. This effect was inhibited by 3-MA
(Fig. 3A). The ability of MSU crystals to induce autophagy was
also demonstrated by LC3B immunoblotting of cell lysates from
PMNs treated for 45 min (Fig. 3B and C). Additionally, treatment
of PMNs with MSU crystals for 3 h did not induce apoptosis or
necrosis (Fig. S3B).
Release of extracellular DNA traps by synovial fluid
neutrophils from patients with acute gout
We further studied whether cells isolated from inflamed joints
from patients with gout could release extracellular fibrous
formations. Formation of extracellular structures, visualized by
staining with DAPI and MPO, by synovial fluid cells was observed
after 3 h of incubation (Fig. 4, Fig. S2). Considering that
neutrophils were the predominant cell population in synovial
fluid (.95%), as demonstrated by May-Grunwald staining (Fig.
S3A), we conclude that this cell type was responsible for this
observation. To explore whether the inflammatory environment of
gout induces the formation of such structures, control PMNs were
treated with synovial fluid derived from inflamed joints. Extensive
NET release was observed under these conditions (Fig. 4), while
treatment with 3-MA or bafilomycin A abrogated this effect
(Fig. 4B).
NET formation by peripheral PMNs from patients with
acute gout
We next investigated whether NET production is a restricted
to affected joints response that depends on the localized
activation of PMNs by MSU crystals or a systemic phenomenon
in the context of gout. Peripheral PMNs from patients with gout
released NETs, determined by co-staining with MPO and DAPI,
when incubated for 3 h in a less prominent way compared to
those observed in synovial fluid cells (Fig. 4). Moreover, treatment
of control PMNs with serum from patients with acute gout had
minimal but statistically significant effect (Fig. 4). PI3K inhibition
or treatment with bafilomycin A effectively blocked this effect
(Fig 4B).
IL-1b blockade attenuates the effect of gouty synovial
fluid on NET formation
Given the previously suggested critical role of IL-1b in the
pathogenesis of gout [6], we studied the possible effect of
inhibition of IL-1 signaling on NET formation. Treatment with
anakinra, a recombinant IL-1 receptor antagonist, partially
inhibited NET production, determined by co-staining with
MPO and DAPI, from control PMNs treated with synovial fluid
from patient with gout (Fig 5). To further implicate IL-1 in this
process, synovial fluid was centrifuged, in order to reduce MSU
crystal concentration. IL-1 signaling inhibition attenuated the
observed NET release from control neutrophils treated with
centrifuged synovial fluid (Fig 5A and B). Moreover, anakinra
completely inhibited the respective effect of serum derived from
patients with acute gout on NET production from control PMNs
(Fig 5B). To discriminate whether the effect of anakinra was due
to the inhibition of IL-1a or IL-1b signaling, centrifuged synovial
fluid was treated with anti-IL-1b monoclonal antibody (mAb)
prior to stimulation of control PMNs (Fig 5B). Both anti-IL-1b
and anakinra treatment had a similar inhibitory effect. Moreover,
incubation of control PMNs with recombinant IL-1b induced the
formation of NETs (Fig 5).
Extracellular DNA structures from synovial fluid
neutrophils are decorated with high mobility group box
chromosomal protein 1 (HMGB1)
Given that HMGB1, an alarmin that activates the innate
immune system [31], has been recently identified in large
amounts on NETs from patients with pediatric SLE [27], its
localization on extracellular DNA web-like formations, assessed
by staining with DAPI, released by synovial fluid PMNs from
patients with acute gout was investigated. We observed that
HMGB1 was localized in the aforementioned extracellular
structures released from synovial fluid PMNs (Fig. 6) or control
PMNs treated with either MSU crystals or synovial fluid from
patients with gout (Fig. 6).
The expression of HMGB1 on extracellular DNA structures
released by control PMNs treated with MSU crystals or synovial
fluid was also demonstrated by immunoblotting of proteins
isolated from these structures. Treatment with bafilomycin A
abrogated this effect (Fig. 6).
NET Formation in Gout
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In this report, we provide for the first time evidence for the
formation of NETs during acute gout. Our experimental data
indicate that inhibition of either phagolysosomal fusion or PI3K
signaling hindered NET release from control neutrophils treated
with MSU crystals. Peripheral and synovial fluid neutrophils
derived from patients with gouty inflammation formed NETs in an
autophagy-dependent manner while synovial fluid from affected
joints and serum derived from patients with gout induced NET
release by control neutrophils. We also provide evidence that IL-
1b signaling is implicated, at least in part, in the formation of
NETs, as shown by the inhibitory effect of anakinra and anti-IL-
1b mAb.
Neutrophils are thought to represent critical effector cells
responsible for gouty inflammation [14]. Neutrophil enzymes
have been previously proposed to participate in the cleavage of
pro-IL-1b in a MSU-driven model of inflammation [7].
Considering that the release of these enzymes promotes tissue
injury and inflammation and since NET formation results in the
extracellular exposure of proteolytic enzymes in the inflamed
tissues, a key role for NET release in the induction of
inflammation during the context of acute gout is suggested.
Moreover, the identification of HMGB1 in NETs released from
synovial fluid neutrophils argues for the pro-inflammatory
potential of these extracellular structures. HMGB1 is a nuclear
protein that acts as an inflammatory mediator for the innate
immune system when released to the extracellular milieu [31].
Even though it has not been directly involved in the pathogenesis
of gout, HMGB1 is implicated in the pathomechanism of
rheumatoid [32] and experimental arthritis [33], suggesting a
possible role in the induction of gouty arthritis.
In this study, 3-MA and LY 294002 were utilized as PI3K
inhibitors and bafilomycin A as an inhibitor of endosomal
acidification. Among other functions, PI3K signaling is crucial in
the initiation of autophagy while early autophagosome fusion with
Figure 1. PMNs treated with MSU crystals release NETs. PMNs from control subjects treated with MSU crystals for different time points. NETs
are assessed by immunofluorescence microscopy after co-staining with DAPI (blue) and MPO (green). Control represents untreated PMNs incubated
for 180 min. Scale bars, 30 mm. Original magnification 400x. One out of three independent experiments is shown. B) Percentage of NET releasing cells
presented in panel A. Data are representative of three independent experiments and presented as mean 6 SD. * P,0.05; ns=non significant
compared to control cells.
doi:10.1371/journal.pone.0029318.g001
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terminal event in this process [20]. In view of the inhibitory effect
of 3-MA and bafilomycin A on NET formation, we propose that
intact autophagic machinery is required for the release of these
extracellular structures. This is in accordance with a recent report
demonstrating that the inhibition of autophagy in neutrophils
treated with phorbol myristate acetate prevented NETosis and led
to apoptotic cell death [21]. However, the interplay between
neutrophil autophagic machinery and NET formation in the
pathogenesis of an inflammatory disorder has not been previously
described. Our findings are in accordance with the previously
described involvement of MSU-containing phagolysosomal for-
mation [34] and PI3K signaling [17,18] in the activation of
neutrophils by MSU crystals. In contrast to previous studies which
demonstrated the implication of Src kinase signaling in the
activation of neutrophils [15], no such correlation was proven in
our model.
NET formation was further associated with IL-1 signaling.
Anakinra partially inhibited NET release from PMNs treated with
synovial fluid derived from patients with active arthritis. When
MSU crystal burden was minimized by centrifugation, the
inhibitory effect of anakinra became more obvious, implying that
Figure 2. PI3K signaling and endosomal acidification is involved in NET release after treatment with MSU crystals. A) Treatment with
3-MA or bafilomycin A prevents the release of NETs from PMNs from control subjects treated with MSU crystals for 180 min. NETs are determined by
co-staining with DAPI (blue) and MPO (green) and visualized by immunofluorescence microscopy. Scale bars, 30 mm. Original magnification 400x.
One out of four independent experiments is shown. B) The effect of treatment with 3-MA, LY294002, bafilomycin A or PP1 in the percentage of NET
releasing PMNs incubated with MSU crystals. Data are representative of four independent experiments and presented as mean 6 SD. * P,0.05;
ns=non significant compared to MSU treated cells.
doi:10.1371/journal.pone.0029318.g002
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crystals. Whether the previously reported role of IL-1b in the
induction of autophagy in human neutrophils [19] is responsible
for this effect cannot be confirmed due to the uniform inhibitory
effect of autophagy inhibition on NET formation. Our data
provide novel insight in the role of IL-1b in the inflammatory
milieu of gout. Concerning the pathogenesis of the disorder, IL-1b
is considered a pivotal cytokine [6]. In addition to the ability of
MSU crystals to induce pro-IL-1b proteolytic cleavage via NLRP3
activation [5], studies in animal models suggest that this cytokine
Figure 3. Induction of autophagy in PMNs treated with MSU crystals. A) Induction of autophagy in control PMNs treated with MSU crystals
for 20 min and 60 min, as assessed by immunofluorescence microscopy of endogenous LC3B. LC3B-positive autophagosome formation was blocked
by 3-MA. DNA is labeled with DAPI (blue). LC3B was stained with polyclonal anti-LC3B Ab (green). Scale bars, 5 mm. Original magnification 1000x. One
out of three independent experiments is shown. B) Induction of LC3B-I to LC3B –II conversion in PMNs treated with MSU crystals for 45 min, as
assessed by immunoblotting. Attenuation of LC3B conversion in PMNs treated with 3-MA. C) Measurement of integrated optical density (IOD) of
bands presented in B, expressed as LC3B-II to LC3B-I ratio 6 SD. Representative data from four independent experiments are shown in B and C.
* P,0.05 compared to MSU treated cells.
doi:10.1371/journal.pone.0029318.g003
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inflammation [8,9], while animals deficient in critical components
of IL-1 signaling were resistant to MSU induced inflammation [8].
The critical role of IL-1b in the pathogenesis of gout was
confirmed by the beneficial clinical outcome of IL-1b blockade in
patients with gout [10–13].
In conclusion, our data indicate that NETs are formed during
inflammatory attacks of gout and suggest a linkage between NET
Figure 4. NET release from synovial cells and peripheral PMNs from patients with gout. A) NET formation by synovial cells, peripheral
PMNs from patients with gout and from control PMNs treated with synovial fluid or serum from patients with gout, as assessed by
immunofluorescense microscopy after co-staining with DAPI (blue) and MPO (green). Inhibitory effect of treatment with 3-MA on the release of NETs
from synovial cells. Scale bars, 30 mm. Original magnification 400x. One out of six independent experiments is shown. B) The effect of treatment with
3-MA or bafilomycin A in the percentage of NET releasing cells presented in panel A. Data are representative of six independent experiments and
presented as mean 6 SD. { P,0.05 compared to control, * P,0.05.
doi:10.1371/journal.pone.0029318.g004
NET Formation in Gout
PLoS ONE | www.plosone.org 6 December 2011 | Volume 6 | Issue 12 | e29318release and signaling involved in autophagy and IL-1 activity. Our
study provides a springboard for further investigation of NET
release in the pathogenesis of inflammatory arthritis. Modulation
of the autophagic machinery may represent an additional
therapeutic target in crystalline arthritis.
Materials and Methods
Patients
Synovial fluid was collected from six patients with active gout
attack, centrifuged at 800x g to separate cells from supernatant.
Figure 5. Implication of IL-1b in the induction of NET release from PMNs treated with synovial fluid or serum from patients with
gout. A) The inhibitory effect of treatment with anakinra on NET release from control PMNs treated with centrifuged or not synovial fluid from
patients with gout, as assessed by immunofluorescense microscopy after co-staining with DAPI (blue) and MPO (green). Treatment with recombinant
IL-1b induces NET release. Scale bars, 30 mm. Original magnification 400x. One out of six independent experiments is shown. B) The inhibitory effect
of anakinra on the percentage of NET releasing PMNs presented in panel A and in PMNs treated with serum from patients with gout. Incubation with
anti-IL-1b mAb reduced the percentage of NET releasing PMNs treated with centrifuged synovial fluid. Data are representative of six independent
experiments and presented as mean 6 SD. { P,0.05 compared to control, * P,0.05.
doi:10.1371/journal.pone.0029318.g005
NET Formation in Gout
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concentration of MSU crystals, synovial fluid was centrifuged at
12000x g for 15 min. A decrease in MSU crystal concentration
greater that 70% was observed after centrifugation, as observed by
microscopy. Synovial fluid cell populations were characterized by
May-Grunwald and indicated a neutrophil predominance
(.90%). Synovial cells were used immediately for determination
of NET formation. Furthermore, PMNs were isolated from
heparinized blood from six patients and six healthy donors by
Histopaque double-gradient density centrifugation as previously
described [35]. Serum was also isolated from patients with gout.
The study protocol design was in accordance of the Declaration of
Helsinki and the procedures have been approved by the local
ethics committee (Scientific Committee of the University Hospital
of Alexandroupolis, Greece). Informed, written consent has been
obtained from all participants involved in the present study.
Figure 6. Localization of HMGB-1 on extracellular fibrous DNA structures. A) Expression of HMGB-1 in extracellular DNA structures released
from PMNs derived from control subjects treated with MSU crystals or synovial fluid and synovial cells from patients with gout, as assessed by
immunofluorescense microscopy. DNA is labeled with DAPI (blue). HMGB-1 is stained with anti-HMGB-1 mAb (green). Control represents untreated
PMNs. One representative out of four independent experiments is shown. Scale bars, 5 mm. Original magnification 1000x. B) Expression of HMGB-1 in
NETs released from control PMNs stimulated with MSU crystals or synovial fluid from patients with gout, as assessed by immunoblotting of NET-
derived proteins. The inhibitory effect of bafilomycin A is shown. One out of three independent experiments is shown.
doi:10.1371/journal.pone.0029318.g006
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Uric acid sodium salt, human recombinant IL-1b, bafilomycin
A, PP1, 49,6-Diamidino-2-phenylindole (DAPI), Limulus amebo-
cyte assay and anti-LC3B polyclonal Ab were purchased from
Sigma-Aldrich (St. Louis, MO). 3-MA and LY 294002 were
purchased from Calbiochem (San Diego, CA), IL-1b mouse mAb
and HRP-conjugated secondary antibody from R&D Systems
(Minneapolis, MN), MPO-specific mouse mAb from DAKO
(Denmark); HMGB1-specific mouse mAb and GAPDH polyclonal
Ab from Abcam (UK), polyclonal rabbit anti-mouse Alexa Fluor
488 Ab and polyclonal goat anti-rabbit Alexa Fluor 488 Ab from
Invitrogen (Carlsbad, CA). In experiments using pharmacological
inhibitors, control PMNs were treated with an equivalent
concentration of vehicle (0.1% DMSO).
MSU crystal preparation
MSU crystals were prepared under pyrogen-free conditions.
Urate acid sodium salt (Sigma-Aldrich) was dissolved in 1 M
NaOH (25 mg/ml) and boiled for 2 hours at 200uC prior to
crystallization. The solution was left to cool at room temperature
and filtered through a 0.2 mM filter. It was then incubated at room
temperature for 7 days. The resulting crystals were washed with
ethanol and acetone and allowed to air dry under sterile
conditions. Triclinic MSU crystals were needle-shaped, between
5 and 20 mm in length and verified to be free of detectable LPS
contamination by the Limulus amebocyte cell lysate assay (Sigma-
Aldrich).
Stimulation and inhibition studies
Neutrophils or synovial fluid cells were incubated at 37uCi na
total volume of 500 ml of RPMI (Gibco BRL, Gaithersburg, MD)
in the presence of 2% serum from healthy donor and different
stimulatory agents. In the set of experiments evaluating the effect
of treatment with MSU crystals, neutrophils were treated for
5 min, 30 min, 90 min and 3 h. To study autophagy induction,
neutrophils were treated for 20, 45 or 60 min [19,21]. Neutrophils
were treated with MSU crystals (250 mg/ml) or synovial fluid
supernatant (20 ml) or serum from patients with gout (20 ml). The
doses were selected according to optimization experiments. Cells
were also stimulated with human recombinant IL-1b (100 ng/ml)
[19]. To inhibit the autophagic machinery, cells were treated with
the PI3K inhibitor 3-MA (5 mM) [19] or LY 294002 (50 mM)
[19], or bafilomycin A (30 nM) [36] for the inhibition of
autophagolysosomal fusion after 30 min of stimulation in order
to permit phagocytosis of crystals to take place. For Src kinase
inhibition the selective inhibitor PP1 (3 and 100 mM) was used. IL-
1b inhibition was performed by Anakinra (Kineret; Amgen/
Biovitrum AB) at a concentration of 100 ng/ml, according to
neutralizing optimization experiments, or a neutralizing IL-1b
mouse monoclonal antibody (10 mg/ml), according to manufac-
turer’s instructions. All experiments were performed in triplicates.
Viability of cells treated with MSU for 3 h was assessed by flow
cytometry using propidium iodide (PI, Sigma-Aldrich) to stain
necrotic cells and an antibody against Annexin-V (BD Biosciences)
as an apoptotic marker. Cells were analyzed in a FACScan flow
cytometer (BD Biosciences). All the materials in this study were
endotoxin free, as determined by a Limulus amebocyte assay.
Immunofluorescence
To visualize NET formation, isolated neutrophils or synovial
fluid cells were seeded in lysine-coated glass coverslips and
prepared as previously described [37]. In brief, cells, after
incubation, were fixed in 4% paraformaldehyde for 2–4 hours at
room temperature. All samples were prepared in triplicates.
Nonspecific binding sites were blocked with 5% rabbit serum in
PBS. NETs were stained using an MPO-specific mouse mAb or an
HMGB-1-specific mouse mAb. A polyclonal rabbit anti-mouse
Alexa Fluor 488 antibody was utilized as secondary. DNA was
counterstained using DAPI. Cell preparations were visualized in a
fluorescence microscope (Leica DM2000). The percentage of cells
undergoing NET release was determined by examining 200 cells
per sample in a double blind fashion.
For LC3B immunofluorescence, neutrophils were prepared as
described above and were stained with an anti-LC3B polyclonal
Ab, followed by a polyclonal goat anti-rabbit Alexa Fluor 488
antibody utilized as secondary. Cells were counterstained using
DAPI.
Protein purification from NETs
NET protein purification was performed as previously described
[38]. In brief, neutrophils were seeded in 6-well culture plates
(Corning Incorporated) in RPMI medium (Gibco BRL). Cells
were incubated for 3 h at 37uC in a 5% CO2 atmosphere.
Approximately 1.5610
6 cells were used for protein purification.
Supernatant was removed and each well was washed twice with
1 mL of pre-warmed RPMI and incubated at 37uC for 10 min.
Extracellular DNA formations were then digested with 10 U/ml
DNase-1 (Fermentas, 798 Cromwell Park, USA) in 1 ml RPMI for
20 min. The activity of DNase-1 was blocked with 5 mM
ethylenediaminetetraacetic acid (EDTA; Applichem, GmbH,
Stockholm, Sweden). Samples were sequentially centrifuged at
300xg to remove whole cells and at 16000xg to remove cellular
debris.
Protein precipitation
Proteins were precipitated with cold acetone from identical
volumes of culture supernatant. Samples were incubated overnight
at 220uC and then centrifuged at 10.000xg for 15 min at 4uC.
The pelleted proteins were lysed in lysis buffer (1% Triton X-100
and 150 mM NaCl in 20 mM HEPES pH 7.5) with protease
inhibitors (Complete Protease Inhibitor Tablets; Roche).
Western blot analysis
Western blot analysis was performed in cells treated for 45 min,
as previously described [19]. Briefly, overnight incubation of the
PVDF membranes was carried out at 4uC using an anti-LC3B
polyclonal Ab (1/1000 dilution). Membranes were probed with
HRP-conjugated secondary antibody (1/2000 dilution) for 45 min
at room temperature. To verify equal loading, membranes were
re-probed for GAPDH. Moreover, HMGB1-specific mouse mAb
(1/1000 dilution) was utilized for the measurement of HMGB1
expressed in NETs, using the same protocol.
Statistical analysis
Data are presented as means 6 SD. Statistical analyses were
performed using unpaired and paired t-test (n,6) and Wilcoxon
paired test (n$6). All statistical analyses were performed with
GraphPad Prism (GraphPad Software, Inc.). P values of #0.05
were considered significant.
Supporting Information
Figure S1 Effect of treatment with PP1 or LY294002 on
the release of NETs from PMNs from control subjects
treated with MSU crystals for 180 min, as assessed by
immunofluorescence microscopy. DNA is labeled with
DAPI (blue) and MPO is stained with anti-MPO mAb (green).
NET Formation in Gout
PLoS ONE | www.plosone.org 9 December 2011 | Volume 6 | Issue 12 | e29318Original magnification 400x. One out of four independent
experiments is shown.
(TIF)
Figure S2 Scatter plot showing the percentage of NET
releasing synovial cells derived from six patients with
gout compared to untreated control PMNs.
(TIF)
Figure S3 A. Cytology. Isolated cells from synovial fluid from a
patient with acute gout demonstrating the prevalence of
neutrophils. Original magnification 1000x. Staining with May-
Grumvald-Giemsa. B. Flow cytometric analysis of cell viability,
using propidium iodide and Annexin-V staining, in untreated
(CONTROL) and MSU treated (MSU) control neutrophils after
3 h of incubation. One out of three independent experiments is
shown.
(TIF)
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